Healthcare-focused holding company Cardiff Lexington files for a $7 million Nasdaq uplisting
I'm PortAI, I can summarize articles.
Cardiff Lexington, a healthcare-focused holding company, has filed with the SEC for a $7 million Nasdaq uplisting. The company, trading under "CDIX" on the OTC, focuses on acquiring middle-market niche clinics in orthopedics, spine care, and pain management. Founded in 1986, it reported $12 million in revenue for the year ending September 30, 2025. R.F. Lafferty & Co. is the sole bookrunner for the deal, with no pricing terms disclosed.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: RenaissanceCapital The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments